MBD

About Us

Professional company for 3D cell culture platform specialized in anticancer drug sensitivity and efficacy/toxicity test.

MBD History

Introducing the footsteps of MBD's growth through constant innovation and continuous research.

  • 2019
  • DecAwarded Small and Medium Business excellence Partner Award (Korea Basic Science Institute)
  • DecObtained IVD CE certification approval (ASFA™ Scanner)
  • NovObtained ISO 13485 certification
  • SeptGrand prize awarded as 2019 Korea Biology leading company
  • SeptObtained FDA medical device certification (ASFA™ Spotter)
  • JunAttend NIH Spring Exhibit 2019 (USA, Bethesda) Display/PR
  • JunObtained FDA medical device certification (ASFA™ Scanner)
  • MaySelected as a start-up leap package business (Ministry of Health and Welfare)
  • AprKFDA medical device manufacture and certification approval (ASFA™ Scanner)
  • FebSelected as an investment-related project for public technology transfer company (Ministry of Science and ICT)
  • JanAttracting VC Series A investment (10 Billion won)
  • 2018
  • DecSet-up liver cancer patient personalized drug screening platform for the Precision medicine (Singapore)
  • SeptKsilink-LIH- MBD research collaboration agreement for personalized cancer drug screening
  • JunSelected as a business growth technology development business (Ministry of SMEs and Startups)
  • FebSLAS exhibition (USA, San Diego) Display /PR
  • 2017
  • OctSelected for military substitute service designated company
  • SeptSelected as pharmaceutical biotechnology advanced technology business (Gyeonggido Business & Science Accelerator)
  • SeptSelected for industry-academic cooperation technology development project (Ministry of SMEs and Startups)
  • JunAttracting VC seeding investment (2 Billion won)
  • FebVenture capital certification
  • JanSinged sales representative agreement with ThermoFisher Scientific
  • JanSelected as KRISS family corporation and technology leading hidden champion training project (Korea Research Institute of Standards and Science)
  • 2016
  • DecSelected as KBSI family corporation (Korea Basic Science Institute)
  • OctFrance Ksilink, Export 3D cell culture /drug screening device (First)
  • 2015
  • MarchEstablished MBD Co., Ltd.